About Jory Bell
Jory Bell is a director at Strand Therapeutics.
Form D filings also name Jory Bell as a director at Mangata Networks.
Jory Bell first appears on SEC filings in 2019.
Experience
This experience comes from Jory Bell's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jory Bell in the role, so the role may have started earlier or lasted longer.
RE
RegCell Current
Board Member
2026 – Present
IN
Insamo Current
Board Member
2026 – Present
SL
Synthetic Design Lab Current
Board Observer
2024 – Present
AB
Amber Bio Current
Board Member
2023 – Present
AA
Atomic AI Current
Board Member
2022 – Present
IN
Infinimmune Current
Board Observer
2022 – Present
MB
Manifold Bio Current
Board Member
2020 – Present
Strand Therapeutics Inc. Current
Director
2019 – Present · Boston, MA
Develops mRNA medicines for people with cancer and autoimmune diseases.
UG
Ultima Genomics Current
Board Member
2017 – Present
PG
Playground Global Current
General Partner
2015 – Present
RS
Relativity Space
Board Member
2018 – 2025
VE
Velo3D
Board Member
2016 – 2022
AC
ACROSANCT
Board Member
2014 – 2017
MI
miselu
CTO / Board Member
2012 – 2015
OQ
OQO
Founder / CEO / Board Member
2000 – 2009
AI
Apple Inc.
Product Designer
1994 – 2000
IB
IBM
Researcher
1994
MI
MIT
Research Associate
1990 – 1994
Key Colleagues at Startups
The people Jory Bell works with at each company, as listed on that company's latest Form D.
Strand Therapeutics Inc. · Form D, Mar 17, 2026
Jeb Keiper
Independent Board Director
Ala Alenazi
Investment and director
Pegah Ebrahimi
Co-founder & Managing Partner, FPV Ventures, director
Tasuku Kitada
President, Head of R&D, Co-founder, director
Samta Kundu
Chief Operating Officer
Jacob Becraft
CEO, Co-Founder and director
Mangata Networks, Inc. · Form D/A, Dec 14, 2023
LS
Larry Schwartz
Chief Operating Officer and director
BH
Brian Holz
Chief Executive Officer and director
JN
Juliette Neu
Executive Vice President, Asia Pacific